A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy
Clinical trial NCT02435108 · COMPLETED
Trial details
- NCT number
- NCT02435108
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-15
- Primary completion
- 2016-01-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.